Charles River Laboratories (CRL) stock news

Charles River Laboratories (CRL) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-22 22:19:29 UTC#503265newconfirmednews

Charles River, Labcorp, and FDA Partner to Standardize Preclinical Abuse Potential Assessment Metrics

reutersimportance 0.40trust 0.90Charles River Laboratories International, Inc. +0.30Laboratory Corporation of America Holdings +0.30U.S. Food and Drug Administration +0.30

2026-10-13 16:34:00 UTC#453800newconfirmednews

Morgan Stanley maintains Charles River Labs at Overweight, raises price target to $340 from $300

dow_jonesimportance 0.40trust 0.70Charles River Laboratories International, Inc. +0.40Morgan Stanley +0.40

2026-10-13 12:00:00 UTC#451952newconfirmednews

Charles River Laboratories to provide viral safety and release testing for Magellan Stem Cells' Zelestrocel program

tradingviewimportance 0.40trust 0.60Charles River Laboratories International, Inc. +0.30Magellan Stem Cells +0.30Zelestrocel +0.30

2026-10-12 16:20:06 UTC#447714newconfirmednews

Charles River Laboratories average analyst price target raised to $324.87, consensus remains Buy

tradingviewimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.20

2026-10-06 12:19:18 UTC#419341duplicateconfirmednews

Charles River Labs and Autolomous launch Apollo Orchestrate digital lab execution platform

seeking alphaimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.30Autolomous Ltd. +0.30Apollo Orchestrate +0.30

2026-10-06 12:00:00 UTC#419180newconfirmednews

Charles River Laboratories launches Apollo Orchestrate to digitize GMP QC workflows in North America and Europe

tradingviewimportance 0.40trust 0.70Charles River Laboratories International, Inc. +0.40Apollo Orchestrate +0.40Autolomous Ltd. +0.30+2 entities

2026-09-30 12:50:00 UTC#391572newconfirmednews

UBS sets $357.00 price target on Charles River Laboratories (CRL)

dow_jonesimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.20UBS Group AG +0.20

2026-09-25 16:39:00 UTC#370014newconfirmednews

Deutsche Bank raises Charles River Laboratories (CRL) price target to $320 from $300

dow_jonesimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.30Deutsche Bank AG +0.30

2026-09-25 14:32:00 UTC#369349newconfirmednews

Evercore ISI Group maintains Outperform rating on Charles River Laboratories

dow_jonesimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.10Evercore ISI Group +0.10

2026-09-25 14:24:39 UTC#369323newconfirmednews

TD Cowen maintains Buy rating on Charles River Laboratories, sets $325 price target

tradingviewimportance 0.40trust 0.70Charles River Laboratories International, Inc. +0.30TD Cowen +0.30

2026-09-25 13:55:00 UTC#369157duplicateconfirmednews

RBC Capital maintains Outperform rating on Charles River Laboratories, raises price target to $322

dow_jonesimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.40RBC Capital Markets, LLC +0.40

2026-09-25 13:45:09 UTC#369060newconfirmednews

RBC Capital maintains Outperform rating on Charles River Laboratories with $322 price target

tradingviewimportance 0.40trust 0.70Charles River Laboratories International, Inc. +0.30RBC Capital Markets, LLC +0.30

2026-09-25 12:42:00 UTC#368715newconfirmednews

Barclays maintains Overweight rating on Charles River Laboratories (CRL)

dow_jonesimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.10Barclays PLC +0.10

2026-09-25 12:25:00 UTC#368567newconfirmednews

Mizuho raises Charles River Laboratories (CRL) price target to $295 from $264, maintains Neutral rating

dow_jonesimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.20Mizuho Financial Group, Inc. +0.20

2026-09-25 02:59:04 UTC#366527newconfirmednews

Baird raises Charles River Laboratories price target to $334 from $291

first_squawkimportance 0.30trust 0.70Charles River Laboratories International, Inc. +0.40Robert W. Baird & Co. Incorporated +0.40

2026-09-24 17:24:17 UTC#364423duplicateconfirmednews

Charles River Laboratories outlines 2030 targets: 5-7% sales CAGR, 24% margins, $300M in AI-driven savings

quartrimportance 0.40trust 0.70Charles River Laboratories International, Inc. +0.40

2026-09-24 14:59:46 UTC#363565duplicateconfirmednews

Charles River Laboratories shares rise following Investor Day outlook reaffirmation

seeking alphaimportance 0.30trust 0.60Charles River Laboratories International, Inc. +0.40

2026-09-24 12:02:00 UTC#362148newconfirmednews

Charles River Laboratories Targets Over $300M in Cumulative Cost Savings from 2027-2030

dow_jonesimportance 0.50trust 0.90Charles River Laboratories International, Inc. +0.40

2026-09-24 12:02:00 UTC#362138newconfirmednews

Charles River Laboratories reaffirms 2026 guidance, expects revenue and adjusted EPS at upper end of ranges

dow_jonesimportance 0.50trust 0.80Charles River Laboratories International, Inc. +0.40

2026-09-24 12:00:00 UTC#362189updateconfirmednews

Charles River Laboratories reaffirms 2026 outlook at high end of ranges, introduces 2030 financial targets

tradingviewimportance 0.50trust 0.70Charles River Laboratories International, Inc. +0.40